185 related articles for article (PubMed ID: 6096974)
1. [Mechanism of action of antiplatelet medication].
Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
[No Abstract] [Full Text] [Related]
2. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
3. [Molecular action of drugs affecting platelet functions (author's transl)].
Verstraete M
Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
[No Abstract] [Full Text] [Related]
4. An overview of antiplatelet and antithrombotic drugs.
Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
[No Abstract] [Full Text] [Related]
5. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte Lecture.
Verstraete M
Haemostasis; 1982; 12(4):317-36. PubMed ID: 6295896
[TBL] [Abstract][Full Text] [Related]
6. Congenital disorders of platelet function.
Rao AK; Holmsen H
Semin Hematol; 1986 Apr; 23(2):102-18. PubMed ID: 3010468
[No Abstract] [Full Text] [Related]
7. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
Gabrielian ES; Akopov SE; Badzhinian SA
Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
[No Abstract] [Full Text] [Related]
8. Evaluation of platelet function.
Day HJ; Rao AK
Semin Hematol; 1986 Apr; 23(2):89-101. PubMed ID: 3010470
[No Abstract] [Full Text] [Related]
9. Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.
Hoet B; Arnout J; Deckmyn H; Vermylen J
Thromb Haemost; 1993 Nov; 70(5):822-5. PubMed ID: 8128441
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
11. [Thrombocyte aggregation inhibitors. A new class of active substances].
Böhm R; Giessler AJ
Pharmazie; 1986 Jan; 41(1):1-7. PubMed ID: 3515372
[No Abstract] [Full Text] [Related]
12. [Status and trends in the field of inhibitors of thrombocyte function].
Glusa E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):575-9. PubMed ID: 6083929
[TBL] [Abstract][Full Text] [Related]
13. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
[No Abstract] [Full Text] [Related]
15. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
Raz A
Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
Spasov AA; Nedogoda VV; Konan K
Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
[No Abstract] [Full Text] [Related]
17. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
18. Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation.
Rao GH; White JG
Am J Hematol; 1985 Aug; 19(4):339-47. PubMed ID: 3161324
[TBL] [Abstract][Full Text] [Related]
19. [Use of a thromboxane synthetase inhibitor for the protection of platelet number and function during extracorporeal circulation. Experimental study].
Massonnet Castel S; Pelissier E; Fabiani JN; Terrier E
Agressologie; 1983 Dec; 24(12):605-8. PubMed ID: 6686919
[No Abstract] [Full Text] [Related]
20. Inhibition of platelet activation by quinones isolated from Auxemma oncocalyx Taub.
Ferreira MA; Nunes OD; Fujimura AH; Pessoa OD; Lemos TL; Viana GS
Res Commun Mol Pathol Pharmacol; 1999; 106(1-2):97-107. PubMed ID: 11127812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
